Last checked at 13 Jun 2017 09:30
13 June 2017
Deltex Medical Group plc
Director/PDMR Shareholding
Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring ("ODM"), announces that it has received notification that on 12 June 2017 its Chairman, Nigel Keen, transferred 1,996,186 Ordinary Shares into The Imperialise Limited Pension Fund at a price of 4.0p per Ordinary Share. Nigel Keen is the principal beneficiary of this fund and following this transaction his beneficial interest remains 26,193,780 Ordinary Shares in the Company representing 8.82% of the total issued share capital of the Company.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
The following notifications are made in accordance with Article 19 of the EU Market Abuse Regulation
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Nigel Keen | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chairman | ||||
b)
| Initial notification /Amendment | Initial | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Deltex Medical Group plc | ||||
b) | LEI | N/A | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p each in Deltex Medical Group plc
Identification code (ISIN) for Deltex Medical Group plc ordinary shares: GB0059337583 | ||||
b) | Nature of the transaction | Transfer of shares into The Imperialise Limited Pension Fund. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
1,996,186 4.0p | ||||
e) | Date of the transaction | 12 June 2017 | ||||
f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | ||||
For further information, please contact:-
Deltex Medical Group plc | 01243 774 837 investorinfo@deltexmedical.com |
Nigel Keen, Chairman | |
Ewan Phillips, Chief Executive Jonathan D Shaw, Finance Director | |
Nominated Adviser & Broker | |
Arden Partners plc | 020 7614 5900 |
Chris Hardie Ciaran Walsh | |
Financial Public Relations | |
IFC Advisory | 0203 053 8671 |
Tim Metcalfe Graham Herring Heather Armstrong |